Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIH SBIR Omnibus Solicitations
National Institutes of Health
National Human Genome Research Institute - Responsibilities of Recipient Institutions in Communicating Research Misconduct to the NIH
National Institutes of Health - Notice to allow SBIR Direct-to-Phase II Application Type for NIAAA-issued Funding Opportunity Announcement PAR-18-786, "Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional)"
National Institute on Alcohol Abuse and Alcoholism - Notice of Webinar and FAQs for NIAID Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) and Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required), RFA-AI-18-046 and RFA-AI-18-047
National Institute of Allergy and Infectious Diseases - REQUEST FOR PROPOSAL (RFP): BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES, RFP-NIAID-DMID-NIHAI201800005
National Institute of Allergy and Infectious Diseases - Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PAR-18-303 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)
National Cancer Institute - Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PAR-18-801 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
National Cancer Institute - Expert Panel Meeting to Discuss Study Design for a Longitudinal Study of the Impact of Prenatal Opioid and other Substance Exposure on Brain and Behavioral Development
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke - Notice of Correction to Application Types Allowed" in PAR-18-522 NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
National Eye Institute - Notice of Correction to Application Types Allowed" in PAR-18-523 NEI Collaborative Clinical Vision Research Project : Chair's Grant (UG1-Clinical Trial Required)
National Eye Institute - Notice of Correction to Application Types Allowed" in PAR-18-521 NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1- Clinical Trial Required)
National Eye Institute - Notice of Intent to Publish a Funding Opportunity Announcement for the Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program
Food and Drug Administration - Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Research on Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) - (U01 Clinical Trial Optional)
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse - Notice of Intent to Publish a Funding Opportunity Announcement for Basic Research on Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse - Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on Cross-Cutting Opportunities (NIH Neuroscience Blueprint)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Nursing Research
Office of Behavioral and Social Science Research - Notice of Clarification: Research Strategy page limit for RFA-NS-18-046 Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke - Notice of Clarification: Research Strategy page limit for PAR-18-548, Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke - Notice of Clarification: Research Strategy page limit for PAR-18-664, Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke - Notice of Clarification: Research Strategy page limit for PAR-18-550, Analytical Validation of a Candidate Biomarker for Neurological Disease (U01) (Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke - Notice of Clarification: Research Strategy page limit for PAR-18-549, Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke - Notice of Availability of Administrative Supplements for Microphysiological Systems Developers : Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose
National Center for Advancing Translational Sciences
National Cancer Institute
National Eye Institute
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse - Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NCATS Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Funding Opportunity Announcement
National Center for Advancing Translational Sciences - Notice of Intent to Publish a Funding Opportunity Announcement to Support Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences - Notice of Intent to Publish a Funding Opportunity Announcement for Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences
Requests for Applications
- Lymphatics in Health and Disease in the Digestive System (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases.
- BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Program Announcements
- Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
National Cancer Institute
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute for Occupational Safety and Health
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp Clinical Trial Optional)
National Center for Complementary and Integrative Health
- Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed)
- Basic Neurodevelopmental Biology of Brain Circuits and Behavior (R21 Clinical Trial Not Allowed)
National Institute of Mental Health
- NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Paul Below at paul-below@uiowa.edu, or Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu.